• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies.

作者信息

Schreiber Karen, Breen Karen, Cohen Hannah, Jacobsen Soren, Middeldorp Saskia, Pavord Sue, Regan Lesley, Roccatello Dario, Robinson Susan E, Sciascia Savino, Seed Paul T, Watkins Linda, Hunt Beverley J

机构信息

Thrombosis and Haemophilia Centre, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.

出版信息

Semin Thromb Hemost. 2017 Sep;43(6):562-571. doi: 10.1055/s-0037-1603359. Epub 2017 Jun 13.

DOI:10.1055/s-0037-1603359
PMID:28609801
Abstract
摘要

相似文献

1
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies.羟氯喹改善抗磷脂抗体女性妊娠结局（HYPATIA）方案：一项关于羟氯喹与安慰剂对比的多中心随机对照试验，该试验纳入患有抗磷脂综合征或抗磷脂抗体的孕妇并在标准治疗基础上加用上述药物。
Semin Thromb Hemost. 2017 Sep;43(6):562-571. doi: 10.1055/s-0037-1603359. Epub 2017 Jun 13.
2
The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.羟氯喹治疗对抗磷脂抗体阳性女性妊娠结局的影响。
Am J Obstet Gynecol. 2016 Feb;214(2):273.e1-273.e8. doi: 10.1016/j.ajog.2015.09.078. Epub 2015 Sep 30.
3
Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?羟氯喹（HCQ）在难治性产科抗磷脂综合征（APS）治疗中有作用吗？
Autoimmun Rev. 2015 Sep;14(9):760-2. doi: 10.1016/j.autrev.2015.04.010. Epub 2015 Apr 29.
4
Pregnancy and Antiphospholipid Syndrome.妊娠与抗磷脂综合征
Semin Thromb Hemost. 2016 Oct;42(7):780-788. doi: 10.1055/s-0036-1592336. Epub 2016 Sep 21.
5
Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.羟氯喹在系统性红斑狼疮及抗磷脂抗体阳性患者中预防血栓形成的应用。
Curr Rheumatol Rep. 2011 Feb;13(1):77-80. doi: 10.1007/s11926-010-0141-y.
6
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study.羟氯喹对抗磷脂综合征产科结局的疗效：来自一项欧洲多中心回顾性研究的数据。
Autoimmun Rev. 2015 Jun;14(6):498-502. doi: 10.1016/j.autrev.2015.01.012. Epub 2015 Jan 21.
7
14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.第十四届抗磷脂抗体国际大会：抗磷脂综合征治疗趋势工作组报告。
Autoimmun Rev. 2014 Jun;13(6):685-96. doi: 10.1016/j.autrev.2014.01.053. Epub 2014 Jan 24.
8
Drs. Lim and Feldman reply.林医生和费尔德曼医生回复。
J Rheumatol. 2013 Oct;40(10):1771-2. doi: 10.3899/jrheum.130692.
9
Commentary on "The risky business of studying prognosis".关于《研究预后的风险业务》的评论
J Rheumatol. 2013 Oct;40(10):1771. doi: 10.3899/jrheum.130393.
10
Analysis of Pregnancy Outcomes in Patients Exhibiting Recurrent Miscarriage With Concurrent Low-Titer Antiphospholipid Antibodies.分析伴有低滴度抗磷脂抗体的复发性流产患者的妊娠结局。
Am J Reprod Immunol. 2024 Nov;92(5):e13940. doi: 10.1111/aji.13940.

引用本文的文献

1
Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis.抗磷脂综合征患者使用羟氯喹与妊娠结局：一项系统评价和荟萃分析
RMD Open. 2025 Aug 27;11(3):e005825. doi: 10.1136/rmdopen-2025-005825.
2
The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review.羟氯喹在风湿性疾病管理中的作用：一项全面综述。
Basic Clin Pharmacol Toxicol. 2025 Aug;137(2):e70082. doi: 10.1111/bcpt.70082.
3
Antiphospholipid syndrome in pregnancy: a comprehensive literature review.
妊娠期抗磷脂综合征：一项全面的文献综述。
BMC Pregnancy Childbirth. 2025 Mar 24;25(1):337. doi: 10.1186/s12884-025-07471-w.
4
Non-Criteria Obstetric Antiphospholipid Syndrome: Myth or Reality?非标准产科抗磷脂综合征：虚构还是现实？
J Clin Med. 2025 Feb 15;14(4):1299. doi: 10.3390/jcm14041299.
5
Hydroxychloroquine: A double‑edged sword (Review).羟氯喹：一把双刃剑（综述）
Mol Med Rep. 2025 Apr;31(4). doi: 10.3892/mmr.2025.13467. Epub 2025 Feb 21.
6
The effects of hydroxychloroquine and its promising use in refractory obstetric antiphospholipid syndrome.羟氯喹及其在难治性产科抗磷脂综合征中的应用前景。
Rheumatol Int. 2024 Feb;44(2):223-234. doi: 10.1007/s00296-023-05457-5. Epub 2023 Sep 23.
7
Preeclampsia and the Antiphospholipid Syndrome.子痫前期与抗磷脂综合征
Biomedicines. 2023 Aug 18;11(8):2298. doi: 10.3390/biomedicines11082298.
8
The pathogenesis of obstetric APS: a 2023 update.产科抗磷脂综合征的发病机制：2023 年更新。
Clin Immunol. 2023 Oct;255:109745. doi: 10.1016/j.clim.2023.109745. Epub 2023 Aug 23.
9
New Ideas for the Prevention and Treatment of Preeclampsia and Their Molecular Inspirations.子痫前期的预防和治疗新思路及其分子启示。
Int J Mol Sci. 2023 Jul 28;24(15):12100. doi: 10.3390/ijms241512100.
10
Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer.羟氯喹在疾病中的生物学功能：从新冠病毒疾病到癌症
Pharmaceutics. 2022 Nov 22;14(12):2551. doi: 10.3390/pharmaceutics14122551.